Эдуард Авербух

Отделение: Офтальмология
Должность: Офтальмолог
Языки: Русский, Иврит
Принимает: только взрослых

Доктор Эдуард Авербух. Руководитель центра офтальмологии в "Хадасса Хар ха-Цофим".

Образование

Родился в Ленинграде, иммигрировал в Израиль в 1976 г. В 1986 получил диплом врача в медицинской школе "Хадасса" при Еврейском университете (Иерусалим)

Специализация

Заболевания сетчатки глаза.

Профессиональная деятельность

  • 1997-1998: консультирующий врач-офтальмолог в офтальмологическом отделении "Хадассы" на горе Скопус
  • 1998-1999: получил специализацию в области заболеваний и хирургии сетчатки и стекловидного тела в университете Торонто (Канада)
  • 1999-по н. вр.: консультирующий врач-офтальмолог в подразделении патологий сетчатки отделения офтальмологии "Хадассы"
  • 2002-по н. вр.: старший врач отделения офтальмологии "Хадассы".

Член Израильской Медицинской Ассоциации, Израильского офтальмологического общества, Американской Академии Офтальмологии, Европейского общества специалистов по лечению патологий сетчатки.

Научные публикации

Characterization of anti-AAV2 neutralizing antibody levels in sheep prior to and following intravitreal AAV2.7m8 injection
Advanced Optical Analysis of Divergence Between the Foci of the Neodymium-Doped Yttrium Aluminum Garnet (Nd:YAG) and Aiming Beam Lasers
Real-World Safety and Effectiveness of Voretigene Neparvovec: Results up to 2 Years from the Prospective, Registry-Based PERCEIVE Study
Central Serous Chorioretinopathy Development following Cessation of Terbinafine Treatment
Cortical Visual Mapping following Ocular Gene Augmentation Therapy for Achromatopsia
Endogenous fungal endophthalmitis: risk factors, clinical course, and visual outcome in 13 patients
Naturally-occurring myopia and loss of cone function in a sheep model of achromatopsia
Correlation of Response between Both Eyes to First- and Second-Line Anti-VEGF Therapy in Diabetic Macular Edema
Evaluation of Photoreceptor Transduction Efficacy of Capsid-Modified Adeno-Associated Viral Vectors Following Intravitreal and Subretinal Delivery in Sheep
Socioeconomic status and visual outcome in patients with neovascular age-related macular degeneration
PERSISTENT LOCULATED SUBRETINAL FLUID AFTER RHEGMATOGENOUS RETINAL DETACHMENT SURGERY
Consecutive unilateral recording of the two eyes affects dark-adapted ERG responses, when compared to simultaneous bilateral recording
Six Years and Counting: Restoration of Photopic Retinal Function and Visual Behavior Following Gene Augmentation Therapy in a Sheep Model of CNGA3 Achromatopsia
Safety and Efficacy Evaluation of rAAV2tYF-PR1.7-hCNGA3 Vector Delivered by Subretinal Injection in CNGA3 Mutant Achromatopsia Sheep
Gene Augmentation Therapy for a Missense Substitution in the cGMP-Binding Domain of Ovine CNGA3 Gene Restores Vision in Day-Blind Sheep
Evaluation of the association of single nucleotide polymorphisms in the PRPH2 gene with adult-onset foveomacular vitelliform dystrophy
Characterising the phenotype and progression of sporadic adult-onset foveomacular vitelliform dystrophy
Gene Augmentation Therapy Restores Retinal Function and Visual Behavior in a Sheep Model of CNGA3 Achromatopsia
Bevacizumab treatment for neovascular age-related macular degeneration in the setting of a clinic: "real life" long-term outcome
Flicker cone function in normal and day blind sheep: a large animal model for human achromatopsia caused by CNGA3 mutation
Bevacizumab treatment for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophy
Association of pattern dystrophy with an HTRA1 single-nucleotide polymorphism
Bevacizumab for choroidal neovascularization related to inflammatory diseases
Irido-cilio-choroidal melanoma in a 5-year-old boy treated by Ru-106 brachytherapy
A novel day blindness in sheep: epidemiological, behavioural, electrophysiological and histopathological studies
Sequence variants in HTRA1 and LOC387715/ARMS2 and phenotype and response to photodynamic therapy in neovascular age-related macular degeneration in populations from Israel
Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel
A novel de novo PAX6 mutation in an Ashkenazi-Jewish family with aniridia
Application of the standard photodynamic treatment protocol for symptomatic circumscribed choroidal hemangioma
Diabetic macular edema: towards therapy aimed at the underlying pathogenic mechanisms
Treatment of ocular tissues exposed to nitrogen mustard: beneficial effect of zinc desferrioxamine combined with steroids
The evidence supporting the early treatment for type 1 retinopathy of prematurity needs further evaluation
Traumatic pediatric retinal detachment: a comparison between open and closed globe injuries
Bilateral iridociliary T-cell lymphoma
Показать ещё 26 статей Скрыть статьи
Заболевания
Ахроматопсия
Процедуры
Генная терапия
Остались вопросы?
Напишите нам и мы свяжемся с вами в течение ближайшего времени и ответим на все интересующие вопросы